Net profit of Aurobindo Pharma rose 7.62% to Rs 910.29 crore in the quarter ended December 2025 as against Rs 845.81 crore during the previous quarter ended December 2024. Sales rose 9.01% to Rs 8604.51 crore in the quarter ended December 2025 as against Rs 7893.15 crore during the previous quarter ended December 2024.
| Particulars | Quarter Ended |
| Dec. 2025 | Dec. 2024 | % Var. |
| Sales | 8604.51 | 7893.15 | 9 |
| OPM % | 20.61 | 19.99 | - |
| PBDT | 1868.58 | 1618.38 | 15 |
| PBT | 1403.85 | 1199.85 | 17 |
| NP | 910.29 | 845.81 | 8 |